Pages that link to "Q80102273"

The following pages link to Lactate, choline, and creatine levels measured by vitro 1H-MRS as prognostic parameters in patients with non-small-cell lung cancer (Q80102273):

Displaying 30 items.

• Identification of Gastric Cancer Biomarkers Using 1H Nuclear Magnetic Resonance Spectrometry (Q28553966) (← links)
• A nonrandomized cohort and a randomized study of local control of large hepatocarcinoma by targeting intratumoral lactic acidosis (Q28831507) (← links)
• Tumor metabolism of lactate: the influence and therapeutic potential for MCT and CD147 regulation (Q33641532) (← links)
• No evident dose-response relationship between cellular ROS level and its cytotoxicity--a paradoxical issue in ROS-based cancer therapy. (Q33647236) (← links)
• Utility of functional imaging in prediction or assessment of treatment response and prognosis following thermotherapy (Q33790254) (← links)
• Study on metabonomic characteristics of human lung cancer using high resolution magic‐angle spinning 1H NMR spectroscopy and multivariate data analysis (Q33882740) (← links)
• Is higher lactate an indicator of tumor metastatic risk? A pilot MRS study using hyperpolarized (13)C-pyruvate. (Q34213179) (← links)
• Inhibition of monocarboxylate transporter-1 (MCT1) by AZD3965 enhances radiosensitivity by reducing lactate transport (Q34646307) (← links)
• Catabolism of exogenous lactate reveals it as a legitimate metabolic substrate in breast cancer. (Q34999491) (← links)
• Magic angle spinning NMR-based metabolic profiling of head and neck squamous cell carcinoma tissues (Q35529046) (← links)
• (1)H nuclear magnetic resonance-based extracellular metabolomic analysis of multidrug resistant Tca8113 oral squamous carcinoma cells (Q35758072) (← links)
• Metabolomics approaches in pancreatic adenocarcinoma: tumor metabolism profiling predicts clinical outcome of patients. (Q36309665) (← links)
• Endostar enhances the antitumor effects of radiation by affecting energy metabolism and alleviating the tumor microenvironment in a Lewis lung carcinoma mouse model (Q36335475) (← links)
• In vivo 1H magnetic resonance spectroscopy of lactate in patients with stage IV head and neck squamous cell carcinoma (Q37012978) (← links)
• Early stage diagnosis of oral cancer using 1H NMR-based metabolomics (Q37109550) (← links)
• Cholinergic Targets in Lung Cancer (Q37127226) (← links)
• Targeted metabolic profiling of hepatocellular carcinoma and hepatitis C using LC-MS/MS. (Q37304708) (← links)
• Buffer Therapy for Cancer (Q37412433) (← links)
• A review of applications of metabolomics in cancer (Q37512830) (← links)
• Studies of Secondary Melanoma on C57BL/6J Mouse Liver Using 1H NMR Metabolomics (Q37608810) (← links)
• How does cancer cell metabolism affect tumor migration and invasion? (Q38153177) (← links)
• Quantification of lactate from various metabolic pathways and quantification issues of lactate isotopologues and isotopmers (Q38621416) (← links)
• Lactate, a putative survival factor for myeloma cells, is incorporated by myeloma cells through monocarboxylate transporters 1. (Q39896435) (← links)
• Noninvasive Monitoring of Radiation-Induced Early Therapeutic Response Using High-resolution MR Imaging and Proton MR Spectroscopy in VX2 Carcinoma (Q42844241) (← links)
• Can nuclear magnetic resonance (NMR) spectroscopy reveal different metabolic signatures for lung tumours? (Q42860801) (← links)
• Lactate and glycine-potential MR biomarkers of prognosis in estrogen receptor-positive breast cancers (Q46383763) (← links)
• Choline kinase alpha in cancer prognosis and treatment (Q46968943) (← links)
• Defining Metabolic Rewiring in Lung Squamous Cell Carcinoma (Q64122535) (← links)
• Central role of lactate and proton in cancer cell resistance to glucose deprivation and its clinical translation (Q89700479) (← links)
• Liquid Biopsy in Lung Cancer Screening: The Contribution of Metabolomics. Results of A Pilot Study (Q92290142) (← links)